Gitte Pedersen is very clear about what role her parents played in the career choices that have led to the now 50-year-old Danish engineer and CEO to an office with a view of the Manhattan skyline as the co-founder and top chief of diagnostics company Genomic Expression.
“I come from a family in which everyone on my father’s side was an engineer or an entrepreneur, so somehow it’s probably in my DNA – and my mother was a first generation women’s rights activist. So there was never any doubt that I was going for a long education; I was just not quite sure about which field to get involved in. I have always been interested in science and I grew up with discussions about the nature of black holes over the dinner table, and at some point I hear about Novo Nordisk on the television,” she tells Medwatch, adding:
Mere fra MedWatch
Venturefonden Sunstone, der for nyligt solgte ud af sine aktier i Orphazyme, afviser ikke på et senere tidspunkt igen at skyde penge i selskabet, der torsdag fik en kold skulder af FDA til selskabets NPC-kandidat. Men fondens formål gør en geninvestering til en svær øvelse, lyder det fra general partner, Sten Verland.